Topics
A to Z
Data &
 Statistics
Forms &
Publications
News &
Advisories
Licensing &
Certification
Rules &
Regulations
Public Health
Directory

Chlamydia trachomatis and Neisseria gonorrhoeae, TMA amplified

Updated

12/2/2016

Other Names Chlamydia (CT) Combo Test; Chlamydia and Gonorrhea Screen; Gonorrhea (GC) Combo Test
How to Order
Check the “Chlamydia/Gonorrhea by NAAT” box under the “Other” heading on the Virology/Immunology Request (form 42).  
Availability
All clients
Methodology
Transcription-Mediated Amplification; Nucleic Acid Hybridization
Performed
Daily on regular business days
Time to Reporting
1-3 working days after receipt of specimen
CPT Code
87801


Specimen Collection Details

Collection
Detailed instructions for collecting, storting, and transporting each acceptable specimen type is provided in the OSPHL Instructions for CT/GC Testing located here: https://public.health.oregon.gov/LaboratoryServices/Documents/OSPHL-CTGC-Instructions.pdf.
Optimal Volume
2 mL urine, not applicable for swabs.
Minimum Volume
2 mL urine, not applicable for swabs.
Handling
All sample types may be stored and transported at 4-30°C.  All sample types are stable for 30 days. 
Transport
All sample types may be stored and transported at 4-30°C.  All sample types are stable for 30 days. 
Transport at ambient or refrigerated temperatures.
Rejection Criteria
Specimens are subject to the requirements of the OSPHL Specimen Submission Policy and Criteria, available at http://bit.ly/SpecimenCriteria.
Specimen rejection criteria specific to CT/GC samples is provided in the OSPHL Instructions for CT/GC Testing located here:https://public.health.oregon.gov/LaboratoryServices/Documents/OSPHL-CTGC-Instructions.pdf.
Comments
The OSPHL has validated the modification of the current FDA approved procedure for CT/GC testing to include rectal and pharyngeal swabs. Only specimen sources detailed in the OSPHL Instructions for CT/GC Testing document provided above are acceptable for testing at the OSPHL.